1. Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study. (21st June 2018) Authors: Cohoon, K. P.; De Sanctis, Y.; Haskell, L.; McBane, R. D.; Spiro, T. E. Journal: Journal of thrombosis and haemostasis Issue: Volume 16:Number 7(2018) Page Start: 1278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗